Milestone Pharmaceuticals

(NASDAQ) MIST

Current Price$1.25

Market Cap$155.62M

Since IPO (2019)-92%

5 Year-79%

1 Year-36%

1 Month-11%

Milestone Pharmaceuticals Financials at a Glance

Market Cap

$155.62M

Revenue (TTM)

$1.78M

Net Income (TTM)

-$68.36M

EPS (TTM)

-$0.68

P/E Ratio

-1.83

Dividend

$0.00

Beta (Volatility)

1.11 (Average)

Dividend

$0.00

Beta (Volatility)

1.11 (Average)

Price

$1.25

Volume

22,034

Open

$1.26

Price

$1.25

Volume

22,034

Open

$1.26

Previous Close

$1.25

Daily Range

$1.24 - $1.27

52-Week Range

$1.00 - $3.06

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

1.11 (Average)

Price

$1.25

Volume

22,034

Open

$1.26

Previous Close

$1.25

Daily Range

$1.24 - $1.27

52-Week Range

$1.00 - $3.06

Estimated Earnings Date

Aug 12, 2026

MIST News

Person in a lab gazing into a microscope

Why Milestone Pharmaceuticals Stock Wilted on Wednesday

Eric VolkmanMay 13, 2026

Should You Buy This Biotech Stock Before It Starts Soaring?

David HaenMar 10, 2020

MIST: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Milestone Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Joseph G. Oliveto, MBA

Website

www.milestonepharma.com

Headquarters

Montreal, QC H4M 2X6, CA

MIST Financials

Key Financial Metrics (TTM)

Gross Margin

94.67%

Operating Margin

-3669.39%

Net Income Margin

-3832.01%

Return on Equity

-339.38%

Return on Capital

-62.39%

Return on Assets

-35.29%

Earnings Yield

-54.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$155.62M

Shares Outstanding

124.50M

Volume

22.03K

Avg. Volume

1.87M

Financials (TTM)

Gross Profit

$1.69M

Operating Income

-$65.46M

EBITDA

-$61.36M

Operating Cash Flow

-$51.21M

Capital Expenditure

-$68.98K

Free Cash Flow

-$51.23M

Cash & ST Invst.

$184.22M

Total Debt

$137.33M

Milestone Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$238.00K

N/A

Gross Profit

$168.00K

N/A

Gross Margin

70.59%

N/A

Market Cap

$155.62M

N/A

Market Cap/Employee

$4.72M

N/A

Employees

N/A

Net Income

-$26.07M

-25.6%

EBITDA

-$21.98M

-11.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$184.22M

+229.2%

Total Debt

$137.33M

+147.1%

Accounts Receivable

$5.00M

+131.4%

Inventory

$1.83M

N/A

Long Term Debt

$136.67M

+148.3%

Short Term Debt

$659.00K

+21.6%

Return on Assets

-35.29%

N/A

Return on Invested Capital

-37.89%

N/A

Free Cash Flow

-$16.05M

-15.0%

Operating Cash Flow

-$16.05M

-15.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IPHAInnate Pharma S.A.

IPHAInnate Pharma S.A.$1.79+0.00%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$3.80-3.31%

PEPGPepGen Inc.

PEPGPepGen Inc.$1.70-0.58%

CRBPCorbus Pharmaceuticals Holdings, Inc.

CRBPCorbus Pharmaceuticals Holdings, Inc.$8.74+5.94%

CRDFCardiff Oncology, Inc.

CRDFCardiff Oncology, Inc.$1.25+3.31%

ELTXElicio Therapeutics, Inc.

ELTXElicio Therapeutics, Inc.$4.00+6.67%

SAVACassava Sciences, Inc.

SAVACassava Sciences, Inc.$1.32+2.33%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$153.23+0.00%

ONDSOndas

ONDSOndas$7.83+0.02%

HLHecla Mining

HLHecla Mining$15.54+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

TAT&T

TAT&T$22.72+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.83-0.04%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.31+0.05%

Questions About MIST

What is the current price of Milestone Pharmaceuticals?

Milestone Pharmaceuticals is trading at $1.25 per share.

What is the 52-week range for Milestone Pharmaceuticals?

Over the past 52 weeks, Milestone Pharmaceuticals has traded between $1.00 and $3.06.

How much debt does Milestone Pharmaceuticals have?

As of the most recent reporting period, Milestone Pharmaceuticals reported total debt of $137.33M.

How much cash does Milestone Pharmaceuticals have on hand?

Milestone Pharmaceuticals reported $71.32M in cash and cash equivalents in its most recent financial results.

What is Milestone Pharmaceuticals’s dividend yield?

Milestone Pharmaceuticals does not currently have a dividend yield.

Milestone Pharmaceuticals

Milestone Pharmaceuticals Financials at a Glance

MIST News

Why Milestone Pharmaceuticals Stock Wilted on Wednesday

Should You Buy This Biotech Stock Before It Starts Soaring?

MIST: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Milestone Pharmaceuticals

MIST Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Milestone Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MIST

What is the current price of Milestone Pharmaceuticals?

What is the 52-week range for Milestone Pharmaceuticals?

How much debt does Milestone Pharmaceuticals have?

How much cash does Milestone Pharmaceuticals have on hand?

What is Milestone Pharmaceuticals’s dividend yield?

Premium Investing Services